These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 261691)

  • 1. Blood levels of flupenthixol in patients with acute and chronic schizophrenia.
    Johnstone EC; Bourne RC; Cotes PM; Crow TJ; Ferrier IN; Owen F; Robinson JD
    Ciba Found Symp; 1979; (74):99-114. PubMed ID: 261691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of depot neuroleptics in tardive dyskinesia.
    Fairbairn AF; Rowell FJ; Hui SM; Hassanyeh F; Robinson AJ; Eccleston D
    Br J Psychiatry; 1983 Jun; 142():579-83. PubMed ID: 6882980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma flupentixol concentrations and clinical response in acute schizophrenia.
    Balant-Gorgia AE; Eisele R; Aeschlimann JM; Balant LP; Garrone G
    Ther Drug Monit; 1985; 7(4):411-4. PubMed ID: 4082241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
    Lipska B; Welbel L; Nurowska K; Szukalski B
    Act Nerv Super (Praha); 1987 Dec; 29(4):270-3. PubMed ID: 3439426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patients.
    Balant-Gorgia AE; Balant LP; Genet C; Eisele R
    Ther Drug Monit; 1985; 7(2):229-35. PubMed ID: 4024219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for flupenthixol in plasma.
    Robinson JD; Risby D
    Clin Chem; 1977 Nov; 23(11):2085-8. PubMed ID: 912874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct radioimmunoassay for flupenthixol in plasma [proceedings].
    Risby D; Robinson JD
    Br J Clin Pharmacol; 1977 Jun; 4(3):407P. PubMed ID: 901730
    [No Abstract]   [Full Text] [Related]  

  • 9. A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum.
    Jørgensen A
    Life Sci; 1978 Oct; 23(15):1533-42. PubMed ID: 569233
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effects of anticholinergic medication on positive schizophrenic symptoms.
    Johnstone EC; Crow TJ; Ferrier IN; Frith CD; Owens DG; Bourne RC; Gamble SJ
    Psychol Med; 1983 Aug; 13(3):513-27. PubMed ID: 6413994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
    Jrgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
    Dencker SJ; Malm U; Jørgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patients.
    Balant-Gorgia AE; Balant LP; Gex-Fabry M; Genet C
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):123-8. PubMed ID: 3691577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
    Wistedt B; Jørgensen A; Wiles D
    Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 16. High dose flupenthixol decanoate in chronic schizophrenia.
    McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
    Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
    Sieberns S
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM; Crow TJ; Johnstone EC; Bartlett W; Bourne RC
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.